Hepabil Therapeutics has been in this business for at least two years. Established under no. 14015033, the company is considered a Private Limited Company. You can contact the office of this firm during office times at the following address: 244 Jiggins Lane, B32 3HJ Birmingham. This firm's classified under the NACE and SIC code 72110 - Research and experimental development on biotechnology.
Presently, this particular company is managed by just one managing director: Daniel-Clement O., who was chosen to lead the company on 31st March 2022.
Daniel-Clement O. is the individual who controls this firm, owns over 3/4 of company shares and has 3/4 to full of voting rights.
(2 pages)